4.7 Article

Diacetylrhein, an anthraquinone antiarthritic agent, suppresses dextran sodium sulfate-induced inflammation in rats: A possible mechanism for a protective effect against ulcerative colitis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Environmental Sciences

Electrocardiographic and histopathological characterizations of diabetic cardiomyopathy in rats

Mahmoud E. Youssef et al.

Summary: Diabetes can lead to abnormal heart function, affecting cardiac structure and causing changes in electrocardiograms, particularly in diabetic rats, such as elevated ST-segment, prolonged QT interval, and QRS complex, which may serve as markers for the development of diabetic cardiomyopathy.

ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2022)

Article Cell Biology

TGF-beta activates NLRP3 inflammasome by an autocrine production of TGF-beta in LX-2 human hepatic stellate cells

Hwansu Kang et al.

Summary: Inflammation contributes to liver disease, and inflammasome activation plays a major role in amplifying liver inflammation. This study investigated the involvement of transforming growth factor-beta (TGF-beta) in inflammasome-mediated fibrosis in hepatic stellate cells. The results showed that TGF-beta increased the activation of NLRP3 inflammasome signaling and the expression of p-Smad2/3-NOX4, leading to increased ROS content and NLRP3 inflammasome activation. NEK7 and active caspase-1 expression were also elevated in TGF-beta-induced cells. Furthermore, TGF-beta secretion levels were significantly increased, and IL-1 beta receptor antagonist treatment inhibited its production. These findings suggest that TGF-beta may act as a danger signal to activate the NLRP3 inflammasome in an autocrine manner, and targeting the NLRP3 inflammasome could be a promising approach for treating TGF-beta-induced liver fibrosis.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2022)

Article Oncology

Molecular mechanism of the TGF-β/Smad7 signaling pathway in ulcerative colitis

Bingqing Bai et al.

Summary: This study found that anti-TNF-alpha and 5-ASA can improve intestinal epithelial permeability in a mouse model of colitis. The protective effects may be mediated by increased TGF-beta expression and/or reduced Smad7 expression, which inhibit epithelial MLCK activity and decrease mucosal permeability.

MOLECULAR MEDICINE REPORTS (2022)

Article Pharmacology & Pharmacy

Diacerein ameliorates induced polycystic ovary in female rats via modulation of inflammasome/caspase1/IL1β and Bax/Bcl2 pathways

Marwa M. M. Refaie et al.

Summary: Polycystic ovary syndrome (PCOS) is a common gynecological disease that affects female fertility. This study evaluated the potential therapeutic effect of diacerein (DIA) on induced PCOS. The results showed that DIA ameliorated PCOS changes mainly through its anti-inflammatory, anti-apoptotic, and antioxidant effects.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2022)

Article Medicine, Research & Experimental

Coomassie brilliant blue G-250 dye attenuates bleomycin-induced lung fibrosis by regulating the NF-κB and NLRP3 crosstalk: A novel approach for filling an unmet medical need

Mona H. Zohny et al.

Summary: CBBG effectively inhibited pulmonary fibrosis and inflammation in a rat model. It exerted lung-protective effects by inactivating NLRP3 inflammasome and NF-kappa B, suggesting its potential clinical applications in the treatment of pulmonary fibrosis.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Article Medicine, Research & Experimental

The dynamic interplay between AMPK/NFκB signaling and NLRP3 is a new therapeutic target in inflammation: Emerging role of dapagliflozin in overcoming lipopolysaccharide-mediated lung injury

Eslam E. Abd El-Fattah et al.

Summary: This study found for the first time that dapagliflozin can reduce the occurrence of acute lung injury in rats by inhibiting oxidative stress and inflammation. The effects of dapagliflozin are mediated through the regulation of the AMPK/NF kappa B pathway and inhibition of NLRP3 activation.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Article Medicine, Research & Experimental

Diacerein protects liver against APAP-induced injury via targeting JNK and inhibiting JNK-mediated oxidative stress and apoptosis

Mengyang Wang et al.

Summary: This study evaluates the pharmacological effects and potential mechanisms of Diacerin in APAP-induced liver injury. The results show that Diacerin can protect the liver from APAP-induced damage by inhibiting JNK kinase phosphorylation.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Article Biochemistry & Molecular Biology

Diacerein ameliorates acetaminophen hepatotoxicity in rats via inhibiting HMGB1/TLR4/NF-κB and upregulating PPAR-γ signal

Gellan Alaa Mohamed Kamel et al.

Summary: DIA exhibits anti-apoptotic, anti-inflammatory, and antioxidant effects against APAP-induced liver injury by inhibiting the HMGB1/TLR4/NF-kappa B pathway and upregulating the expression of PPAR-gamma.

MOLECULAR BIOLOGY REPORTS (2022)

Article Pharmacology & Pharmacy

Carbocisteine as a Modulator of Nrf2/HO-1 and NF?B Interplay in Rats: New Inspiration for the Revival of an Old Drug for Treating Ulcerative Colitis

Amir Mohamed Abdelhamid et al.

Summary: This study investigated the potential coloprotective role of carbocisteine in acetic acid-induced colitis in rats. The results showed that carbocisteine improved colon histology, macroscopic features, and disease activity. It also enhanced colon antioxidant defense mechanisms, suppressed neutrophil infiltration and activation, and modulated the expression of multiple cytokines. The study suggests that carbocisteine has the potential to be repurposed as a treatment for ulcerative colitis.

FRONTIERS IN PHARMACOLOGY (2022)

Article Medicine, Research & Experimental

Combining the HSP90 inhibitor TAS-116 with metformin effectively degrades the NLRP3 and attenuates inflammasome activation in rats: A new management paradigm for ulcerative colitis

Ahmed A. Shaaban et al.

Summary: The study evaluated the effect of autophagy induction and HSP90 inhibition in colitis-related diseases, revealing that the combination treatment was effective in combating colon damage and immune-cell infiltration. Further biochemical analysis showed reduced inflammation and oxidative injury.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Article Medicine, Research & Experimental

Albendazole-loaded cubosomes interrupt the ERK1/2-HIF-1α-p300/CREB axis in mice intoxicated with diethylnitrosamine: A new paradigm in drug repurposing for the inhibition of hepatocellular carcinoma progression

Sameh Saber et al.

Summary: The study found that albendazole can inhibit hepatocellular carcinoma through various mechanisms, including antioxidative stress, liver function improvement, antiangiogenic, antimetastatic, apoptosis induction, and antiproliferative activities. These effects contribute to increased survival rates for patients with HCC.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Review Biochemistry & Molecular Biology

NLRP3 Inflammasome in Diabetic Cardiomyopathy and Exercise Intervention

Yi Sun et al.

Summary: The study investigates the link between diabetic cardiomyopathy (DCM) and NLRP3 inflammasome, indicating that NLRP3 inflammasome-mediated inflammatory response exacerbates DCM. Exercise training plays an important role in alleviating DCM.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Medicine, Research & Experimental

Diacerein protects rats with liver ischemia/reperfusion damage: Down-regulation of TLR4/ NFκ-B signaling pathway

Mohamed Abdellah Ibrahim et al.

Summary: The study demonstrated that diacerein pretreatment can reduce liver enzyme levels, oxidative stress, and hepatic inflammation by down-regulating the TLR4/NF kappa-B signaling pathway to restore the damaging effects of liver I/R. This hepatoprotective effect is attributed to the antioxidant and anti-inflammatory properties of diacerein, highlighting its potential as a therapeutic agent for liver I/R injury.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Medicine, Research & Experimental

Blunting p38 MAPKa and ERK1/2 activities by empagliflozin enhances the antifibrotic effect of metformin and augments its AMPK-induced NF-κB inactivation in mice intoxicated with carbon tetrachloride

Amir Mohamed Abdelhamid et al.

Summary: The study investigated the hepatoprotective effects of metformin and empagliflozin combined therapy in a hepatic fibrosis model in mice induced by carbon tetrachloride. Results showed that the combination therapy exhibited complementary effects in preventing hepatic inflammation and fibrosis, particularly in diabetic patients, by enhancing antifibrotic effect and AMPK-induced NF-kappa B inactivation.

LIFE SCIENCES (2021)

Article Medicine, Research & Experimental

BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by targeting P2X7R/NLRP3 and MyD88/NF-κB signaling in DSS-induced colitis in rats

Sameh Saber et al.

Summary: The study showed that the P2X7R blocker BBG and the selective NLRP3 inhibitor OLT1177, when used individually or in combination, effectively treated ulcerative colitis by reducing inflammation and repairing colonic damage. The combined administration of BBG and OLT1177 exhibited a stronger inhibitory effect on NLRP3 signaling.

LIFE SCIENCES (2021)

Article Pharmacology & Pharmacy

NLRP3 inflammasome mediated pyroptosis is involved in cadmium exposure-induced neuroinflammation through the IL-1β/IkB-α-NF-κB-NLRP3 feedback loop in swine

Jingzeng Cai et al.

Summary: The study found that Cd-induced neurotoxicity causes neuroinflammation by activating pyroptosis and increasing the production of inflammatory cytokines, affecting multiple key signaling pathways and gene expressions.

TOXICOLOGY (2021)

Article Immunology

Dapagliflozin, an SGLT2 inhibitor, ameliorates acetic acid-induced colitis in rats by targeting NFκB/AMPK/NLRP3 axis

Magdy Abou El-Rous et al.

Summary: The study found that dapagliflozin has a coloprotective effect in rats with acetic acid-induced UC, improving tissue damage, prolonging survival, reducing disease activity, and modulating the expression of inflammatory and anti-inflammatory factors at the molecular level.

INFLAMMOPHARMACOLOGY (2021)

Article Chemistry, Medicinal

A Novel Combination Therapy Using Rosuvastatin and Lactobacillus Combats Dextran Sodium Sulfate-Induced Colitis in High-Fat Diet-Fed Rats by Targeting the TXNIP/NLRP3 Interaction and Influencing Gut Microbiome Composition

Sameh Saber et al.

Summary: The study demonstrated that an HFD exacerbates intestinal inflammation in DSS-induced colitis in rats, while rosuvastatin/Lactobacillus therapy significantly inhibited inflammation and improved intestinal health. The combination therapy also reduced inflammation markers and inhibited NLRP3 inflammasome activation, offering a safe and effective strategy for managing ulcerative colitis.

PHARMACEUTICALS (2021)

Article Cell Biology

Diacerein Inhibits Myopia Progression through Lowering Inflammation in Retinal Pigment Epithelial Cell

Peng-Tai Tien et al.

Summary: The study showed that diacerein has a therapeutic effect on myopia, potentially by regulating the expression of various biomarkers to inhibit the progression of myopia.

MEDIATORS OF INFLAMMATION (2021)

Article Pharmacology & Pharmacy

Interference With the AMPKα/mTOR/NLRP3 Signaling and the IL-23/IL-17 Axis Effectively Protects Against the Dextran Sulfate Sodium Intoxication in Rats: A New Paradigm in Empagliflozin and Metformin Reprofiling for the Management of Ulcerative Colitis

Mahmoud E. Youssef et al.

Summary: The combination of empagliflozin and metformin can mitigate ulcerative colitis by enhancing AMPK phosphorylation, inhibiting mTOR and NLRP3 expression, reducing caspase-1 cleavage, and inhibiting inflammatory cytokines. This combination also reduces Th17 cell polarization, maintaining immune homeostasis and showing potential as a novel therapeutic approach for treating diabetic patients with ulcerative colitis.

FRONTIERS IN PHARMACOLOGY (2021)

Article Immunology

The Supportive Role of NSC328382, a P2X7R Antagonist, in Enhancing the Inhibitory Effect of CRID3 on NLRP3 Inflammasome Activation in Rats with Dextran Sodium Sulfate-Induced Colitis

Sameh Saber et al.

Summary: The combination therapy of NSC328382/CRID3 showed significantly increased efficacy in treating ulcerative colitis, improving colon health, antioxidant functions, and reducing inflammation by downregulating proinflammatory cytokines. NSC328382 also interrupted the MyD88/NF-Kappa B axis and altered Th1/Th2 dominance. This suggests a novel approach for treating IBDs with potential clinical applications.

JOURNAL OF INFLAMMATION RESEARCH (2021)

Article Instruments & Instrumentation

In vitro and in vivo evaluation of cubosomal nanoparticles as an ocular delivery system for fluconazole in treatment of keratomycosis

Mohamed Nasr et al.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2020)

Review Immunology

The IL-1 family cytokines and receptors in autoimmune diseases

Paola Migliorini et al.

AUTOIMMUNITY REVIEWS (2020)

Review Pharmacology & Pharmacy

Cytokines in inflammatory bowel diseases - Update 2020

M. Leppkes et al.

PHARMACOLOGICAL RESEARCH (2020)

Review Gastroenterology & Hepatology

Surgical Management of Ulcerative Colitis

Michael J. Grieco et al.

GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2020)

Review Medicine, Research & Experimental

Diacerein: Recent insight into pharmacological activities and molecular pathways

Maged Almezgagi et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Review Biochemistry & Molecular Biology

The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation

Nathan Kelley et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Medicine, General & Internal

Ulcerative Colitis

Joseph D. Feuerstein et al.

MAYO CLINIC PROCEEDINGS (2019)

Article Multidisciplinary Sciences

Caspase-1 initiates apoptosis in the absence of gasdermin D

Kohsuke Tsuchiya et al.

NATURE COMMUNICATIONS (2019)

Review Biochemistry & Molecular Biology

Modulatory Mechanisms of the NLRP3 Inflammasomes in Diabetes

Sujuan Ding et al.

BIOMOLECULES (2019)

Review Immunology

NLRP3 Inflammasome and Inflammatory Bowel Disease

Yu Zhen et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Immunology

Overview of the IL-1 family in innate inflammation and acquired immunity

Charles A. Dinarello

IMMUNOLOGICAL REVIEWS (2018)

Article Medicine, Research & Experimental

Tranilast directly targets NLRP3 to treat inflammasome-driven diseases

Yi Huang et al.

EMBO MOLECULAR MEDICINE (2018)

Article Biochemistry & Molecular Biology

Diacerein alleviates kidney injury through attenuating inflammation and oxidative stress in obese insulin-resistant rats

Nuttawud Chueakula et al.

FREE RADICAL BIOLOGY AND MEDICINE (2018)

Article Multidisciplinary Sciences

OLT1177, a ß-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation

Carlo Marchetti et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Review Peripheral Vascular Disease

Role of NLRP3 Inflammasomes in Atherosclerosis

Tadayoshi Karasawa et al.

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2017)

Review Gastroenterology & Hepatology

TGF-β in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota

Sozaburo Ihara et al.

JOURNAL OF GASTROENTEROLOGY (2017)

Review Cardiac & Cardiovascular Systems

Interleukin-1 Beta as a Target for Atherosclerosis Therapy Biological Basis of CANTOS and Beyond

Peter Libby

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Review Public, Environmental & Occupational Health

Benefit-Risk Assessment of Diacerein in the Treatment of Osteoarthritis

Elena Panova et al.

DRUG SAFETY (2015)

Article Gastroenterology & Hepatology

The TGF-β/Smad System in IBD Pathogenesis

Silvia Sedda et al.

INFLAMMATORY BOWEL DISEASES (2015)

Article Biochemistry & Molecular Biology

The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease

Yun-Hee Youm et al.

NATURE MEDICINE (2015)

Review Pharmacology & Pharmacy

IL-1β and IL-18: inflammatory markers or mediators of hypertension?

S. M. Krishnan et al.

BRITISH JOURNAL OF PHARMACOLOGY (2014)

Article Gastroenterology & Hepatology

Effects of rhein on intestinal epithelial tight junction in IgA nephropathy

Sheng-Nan Peng et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2013)

Article Cell Biology

Multiple Functions of BCL-2 Family Proteins

J. Marie Hardwick et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)

Editorial Material Cell Biology

Mitochondrial ROS fuel the inflammasome

Matthew T. Sorbara et al.

CELL RESEARCH (2011)

Review Allergy

Cryopyrin-Associated Periodic Syndrome: An Update on Diagnosis and Treatment Response

Justin R. Yu et al.

CURRENT ALLERGY AND ASTHMA REPORTS (2011)

Article Medicine, Research & Experimental

PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice

Wei Qiu et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Review Oncology

Apoptosis in cancer: from pathogenesis to treatment

Rebecca S. Y. Wong

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)

Article Multidisciplinary Sciences

A role for mitochondria in NLRP3 inflammasome activation

Rongbin Zhou et al.

NATURE (2011)

Review Pathology

Oxidative stress in ulcerative colitis-associated carcinogenesis

A. Roessner et al.

PATHOLOGY RESEARCH AND PRACTICE (2008)

Article Surgery

Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis

Lisa S. Poritz et al.

JOURNAL OF SURGICAL RESEARCH (2007)

Article Immunology

Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappa B activity: a role for p50

F Driessler et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)

Article Pharmacology & Pharmacy

Pharmacological studies of diacerein in animal models of inflammation, arthritis and bone resorption

T Tamura et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2002)